Novel vaccine safety issues and areas that would benefit from further research

Novel vaccine safety issues and areas that would benefit from further research

Bibliographic Details
Main Authors: Annelies Wilder-Smith, Peter G Smith, Jacqueline E Tate, Umesh D Parashar, Daniel A Salmon, Paul Henri Lambert, Hanna M Nohynek, Julianne Gee, Kenneth Y Hartigan-Go, Patrick Louis F Zuber
Format: Article
Language:English
Published: BMJ Publishing Group 2021-05-01
Series:BMJ Global Health
Online Access:https://gh.bmj.com/content/6/Suppl_2/e003814.full
id doaj-bc4659af389c4d0082515149a5bb944e
record_format Article
spelling doaj-bc4659af389c4d0082515149a5bb944e2021-06-27T10:00:05ZengBMJ Publishing GroupBMJ Global Health2059-79082021-05-016Suppl 210.1136/bmjgh-2020-003814Novel vaccine safety issues and areas that would benefit from further researchAnnelies Wilder-Smith0Peter G Smith1Jacqueline E Tate2Umesh D Parashar3Daniel A Salmon4Paul Henri Lambert5Hanna M Nohynek6Julianne Gee7Kenneth Y Hartigan-Go8Patrick Louis F Zuber9Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, SingaporeMRC Tropical Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UKDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USADivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USAGlobal Disease Epidemiology and Control, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USACentre of Vaccinology, University of Geneva, Geneva, GE, SwitzerlandInfectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Uusimaa, FinlandDivision of Healthcare Quality Promotion, National Center of Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, USAAsian Institute of Management, Makati City, PhilippinesEssential Medicines and Health Products, Organisation Mondiale de la Sante, Geneve, Switzerlandhttps://gh.bmj.com/content/6/Suppl_2/e003814.full
collection DOAJ
language English
format Article
sources DOAJ
author Annelies Wilder-Smith
Peter G Smith
Jacqueline E Tate
Umesh D Parashar
Daniel A Salmon
Paul Henri Lambert
Hanna M Nohynek
Julianne Gee
Kenneth Y Hartigan-Go
Patrick Louis F Zuber
spellingShingle Annelies Wilder-Smith
Peter G Smith
Jacqueline E Tate
Umesh D Parashar
Daniel A Salmon
Paul Henri Lambert
Hanna M Nohynek
Julianne Gee
Kenneth Y Hartigan-Go
Patrick Louis F Zuber
Novel vaccine safety issues and areas that would benefit from further research
BMJ Global Health
author_facet Annelies Wilder-Smith
Peter G Smith
Jacqueline E Tate
Umesh D Parashar
Daniel A Salmon
Paul Henri Lambert
Hanna M Nohynek
Julianne Gee
Kenneth Y Hartigan-Go
Patrick Louis F Zuber
author_sort Annelies Wilder-Smith
title Novel vaccine safety issues and areas that would benefit from further research
title_short Novel vaccine safety issues and areas that would benefit from further research
title_full Novel vaccine safety issues and areas that would benefit from further research
title_fullStr Novel vaccine safety issues and areas that would benefit from further research
title_full_unstemmed Novel vaccine safety issues and areas that would benefit from further research
title_sort novel vaccine safety issues and areas that would benefit from further research
publisher BMJ Publishing Group
series BMJ Global Health
issn 2059-7908
publishDate 2021-05-01
url https://gh.bmj.com/content/6/Suppl_2/e003814.full
work_keys_str_mv AT annelieswildersmith novelvaccinesafetyissuesandareasthatwouldbenefitfromfurtherresearch
AT petergsmith novelvaccinesafetyissuesandareasthatwouldbenefitfromfurtherresearch
AT jacquelineetate novelvaccinesafetyissuesandareasthatwouldbenefitfromfurtherresearch
AT umeshdparashar novelvaccinesafetyissuesandareasthatwouldbenefitfromfurtherresearch
AT danielasalmon novelvaccinesafetyissuesandareasthatwouldbenefitfromfurtherresearch
AT paulhenrilambert novelvaccinesafetyissuesandareasthatwouldbenefitfromfurtherresearch
AT hannamnohynek novelvaccinesafetyissuesandareasthatwouldbenefitfromfurtherresearch
AT juliannegee novelvaccinesafetyissuesandareasthatwouldbenefitfromfurtherresearch
AT kennethyhartigango novelvaccinesafetyissuesandareasthatwouldbenefitfromfurtherresearch
AT patricklouisfzuber novelvaccinesafetyissuesandareasthatwouldbenefitfromfurtherresearch
_version_ 1721358439099138048

Similar Items